-
-
-
-
-
-
-
Liquidia Technologies (LQDA) Announces $100 Million in New Financings
-
-
-
-
-
-
-
Liquidia Technologies (LQDA) Enters Interest Financing Agreement With HealthCare Royalty for Up to $100M
-
-
-
-
-
-
-
Liquidia Reports Third Quarter 2021 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
Liquidia Resubmits New Drug Application for LIQ861 (treprostinil) Inhalation Powder for the Treatment of Pulmonary Arterial Hypertension
-
-
-
-
-
-
-
Liquidia Announces Generic Treprostinil Injection Will Be Available for Subcutaneous Route of Administration
-
-
-
-
-
-
-
Liquidia Technologies (LQDA) Appoints Michael Kaseta Chief Financial Officer
-
-
-
-
-
-
-
Liquidia Reports Third Quarter 2020 Financial Results and Provides Corporate Update
-
1,199,267 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


